Columbia IMPAACT CRS

New York, New York 10032

0 studies enrolling now · 35 studies all time

What they study most

Chickenpox, Cytomegalovirus Infections, H1N1 Influenza Virus, HIV Infections, HIV Seronegativity, Hepatitis B, Influenza, Measles, Meningitis, Parainfluenza Virus 3, Human, Pertussis, Pneumococcal Infections

Studies at this site

• Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy — Completed
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth — Completed
• Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women — Completed
• Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children — Completed
• A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children — Completed
• Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women — Completed
• Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection — Completed
• A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers — Completed
• A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection — Completed
• Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children — Completed
• A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT — Completed
• Optimizing Treatment for Treatment-Experienced, HIV-Infected People — Completed
• A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection — Completed
• Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth — Completed
• A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease — Completed
• Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents — Completed
• Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems — Completed
• Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment — Completed
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs — Completed
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy — Completed
• Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy — Completed
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents — Completed
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy — Completed
• Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox — Completed
• A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers — Completed
• A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children — Completed
• A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine — Completed
• A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women — Completed
• A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children — Completed
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group — Completed
• A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants — Completed
• A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT — Completed
• Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children — Completed
• Blood Levels of Abacavir in HIV Infected Adolescents — Completed
• The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV — Completed